
Anjali T Owens MD
Adult Congenital Heart Disease, Cardiac Electrophysiology, Heart Failure & Transplantation, Interventional Cardiology
Assistant Professor, Medicine, Perelman School of Medicine
Join to View Full Profile
3400 Spruce StPhiladelphia, PA 19104
Phone+1 215-314-0343
Dr. Owens is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Pennsylvania Health SystemFellowship, Cardiovascular Disease, 2010 - 2011
- University of Pennsylvania Health SystemFellowship, Cardiovascular Disease, 2007 - 2010
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2003 - 2006
- Duke University School of MedicineClass of 2003, B.A.
Certifications & Licensure
- PA State Medical License 2003 - 2026
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
- DCM Precision Medicine Study Start of enrollment: 2016 Jun 07
Publications & Presentations
PubMed
- Prognostic Value of Compact Myocardial Thinning in Patients with Left Ventricular Non-compaction.Tea Gegenava, Martijn Tukker, Kadir Caliskan, Alexander Hirsch, Ashish Manohar
The American Journal of Cardiology. 2025-04-22 - Clinical Validity of Autosomal DominantLoss-of-Function Variants as a Cause of Hypertrophic Cardiomyopathy.Sophie Hespe, Emma S Singer, Chloe Reuter, Brittney Murray, Elizabeth Jordan
Circulation. Genomic and Precision Medicine. 2025-04-21 - Response to Mavacamten in Patients With High Baseline Left Ventricular Filling Pressures in the EXPLORER-HCM Trial.Sharon Cresci, Richard G Bach, Anjali T Owens, Neal K Lakdawala, Sara Saberi
Circulation. Cardiovascular Imaging. 2025-04-08
Journal Articles
- Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients with Heart Failure with Reduced Ejection Fraction in US Clinical PracticeMuthiah Vaduganathan, Javed Butler, Paul A Heidenreich, Michelle M Kittleson, Anjali Tiku Owens, Pamela N Peterson, Clyde W Yancy, Gregg C Fonarow, JAMA Cardiology
Authored Content
- Diagnosis of Hypertrophic Cardiomyopathy: What Every Cardiologist Needs to KnowFebruary 2020
- Diagnosis of Hypertrophic Cardiomyopathy: What Every Cardiologist Needs to KnowFebruary 2020
Press Mentions
- Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific SessionsSeptember 27th, 2024
- U.S. Food and Drug Administration Approves Camzyos™ (Mavacamten) for the Treatment of Adults with Symptomatic New York Heart Association Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) to Improve Functional Capacity and SymptomsApril 29th, 2022
- FDA Approves Mavacamten, First Treatment for Obstructive Hypertrophic CardiomyopathyApril 29th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: